Home/ Supplements/ Echinacea/ Echinacea 400 mg

Echinacea 400 mg

product on market Tablet or Pill Hi-Tech Pharmaceuticals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

This product contains extracts from Echinacea purpurea and Echinacea angustifolia, which are researched for their potential to support immune function. There is moderate evidence suggesting these ingredients may reduce the duration of common cold symptoms. However, overall evidence coverage for this specific formulation remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Echinacea 400 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
120
Servings
Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 400.0mg (380 products) 36 studies (A:1, B:10)
Market median: 400.0mg (380 products) 36 studies (A:1, B:10)
Market median: 400.0mg (380 products) 36 studies (A:1, B:10)

Other Ingredients

Cyclosome Technology with Phospholipids
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one (1) tablet (1 to 4 times daily as needed).

Formulation Notes

Echinacea is at the very top of the list as one of the most well-known, researched, and respected immune-supporting herbs. Its popularity hinges on its tried and true ability to work with your own natural defenses to support a healthy immune response. Hi-Tech Pharmaceuticals has the state-of-the-art extract with the fullest range of echinacea's most powerful & beneficial immune-boosting compounds. Our supercritical CO2 extract process provides a whole spectrum of echinacea purpurea's alkylamides, cichoric acid, polyphenols & beta-1,2-D-fructofuranosides with echinacea angustifolia's echinacosides. Hi-Tech utilizes the most advanced multi-faceted extracts with the fullest range of echinacea's most beneficial immune compounds extracts from echinacea purpura aerials & root and echinacea angustifolia root maximize the full array of immune-boosting benefits. Hi-Tech's super ingredient provides you with the best power for seasonal strength.

Standardized extracts boost immune response and strengthens your wellness. The powerful combination supports your health from the inside.

Our scientifically advanced Cyclosome Technology sets our ingredients apart using natural liposomes to protect the echinacea through digestion and a starch cyclodextrin for optimal absorption. Introducing the most bioavailable echinacea on the market.

Cyclosome Delivery for enhanced bioavailability Supports healthy white blood cells Supports a healthy immune system

Echinacea 400 mg per tablet

(Non-GMO)

Additional Information

Good Manufacturing Practice Sourced from a GMP Certified Facility Quality Assured

Metadata

Product Details

UPC / SKU8 11836 02444 9
DSLD Entry Date2020-07-23
Product TypeBotanical
FormTablet or Pill
DSLD ID229639
Data Updated2026-04-11
Research

Research Evidence

38
Research Sources
52
Avg Quality
15
Meta Analysis
12
Systematic Review
6
Rct
2
Clinical Trial
1
Regulatory Source
1
Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025 PubMed DOI
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024 PubMed DOI
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024 PubMed DOI
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018 PubMed DOI
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007 PubMed
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015 PubMed DOI
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
View all evidence for Echinacea →
Compare

Similar Products

View all Echinacea products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.